Legence Corp.
LGN Nasdaq Construction - Special Trade Contractors Financials FY2023βFY2025
What Legence Corp. does
No business description yet.
- Legal name
- Legence Corp.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 30, 2026
- Accession Β· CIK
- 0002052568-26-000008
0002052568
Revenue and margins
Legence Corp. had $2.6B of revenue in fiscal 2025, up 21.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $219M in fiscal 2025, 8.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Legence Corp. returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Legence Corp. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | β | $81.2M | $230M |
| Debt incl. finance leases | β | $1.6B | $840M |
| Net debt / EBITDA | β | 9.2x | 3.8x |
| Debt / equity | β | β | 2.1x |
| Interest coverage | 0.2x | 0.8x | 0.6x |
| Current ratio | β | 1.8x | 1.6x |
| Quick ratio | β | 1.8x | 1.6x |
| Total assets | β | $2.4B | $2.7B |
| Total liabilities | β | $2.1B | $1.9B |
| Shareholders' equity | β | β | $392M |
| Net debt (β = net cash) | β | $1.5B | $610M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 4 | 5 / 8 |
| Accruals ratio | β | β2.5% | β12.6% |
| Altman Z'' | β | β | 0.98 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $1.6B | $2.1B | $2.6B |
| Gross profit | $315M | $431M | $536M |
| Operating income | $10.3M | $70.4M | $61.6M |
| Interest expense | $68.2M | $91.6M | $102M |
| Pretax income | β$53.9M | β$23.1M | β$55.1M |
| Income tax | β$7.9M | $4.5M | $22.2M |
| Net income | β$46.0M | β$28.6M | β$59.8M |
| Cash flow | |||
| Cash from operations | $33.9M | $29.3M | $257M |
| Capital expenditure | $17.1M | $19.0M | $37.9M |
| Free cash flow | $16.8M | $10.3M | $219M |
| Depreciation and amortization | $80.2M | $97.2M | $100M |
| Stock-based compensation | $10.1M | $5.4M | $67.6M |
| Acquisitions | $120M | $225M | $16.5M |
| Balance sheet | |||
| Cash and short-term investments | β | $81.2M | $230M |
| Total debt | β | $1.6B | $829M |
| Finance lease liabilities | β | $7.2M | $10.6M |
| Current assets | β | $756M | $1.1B |
| Current liabilities | β | $411M | $708M |
| Inventory | β | $10.2M | $11.3M |
| Property and equipment, net | β | $73.4M | β |
| Goodwill | $676M | $781M | $764M |
| Intangible assets | β | $624M | $551M |
| Total assets | β | $2.4B | $2.7B |
| Total liabilities | β | $2.1B | $1.9B |
| Preferred stock | β | β | $0.0M |
| Shareholders' equity | β | β | $392M |
| Margins | |||
| Gross margin | 19.5% | 20.5% | 21.0% |
| Operating margin | 0.6% | 3.4% | 2.4% |
| EBITDA margin | 5.6% | 8.0% | 6.3% |
| Net margin | β2.8% | β1.4% | β2.3% |
| FCF margin | 1.0% | 0.5% | 8.6% |
| Returns | |||
| Return on capital | β | β | 4.9% |
| Return on capital employed | β | 3.6% | 3.1% |
| Return on equity | β | β | β15.2% |
| Return on assets | β | β1.2% | β2.4% |
| Growth | |||
| Revenue growth | β | 29.9% | 21.5% |
| FCF growth | β | β39.1% | 2,033.8% |
| Financial health | |||
| Net debt / EBITDA | β | 9.2x | 3.8x |
| Debt / equity | β | β | 2.1x |
| Interest coverage | 0.2x | 0.8x | 0.6x |
| Current ratio | β | 1.8x | 1.6x |
| Quick ratio | β | 1.8x | 1.6x |
| Capital allocation | |||
| Capex / revenue | 1.1% | 0.9% | 1.5% |
| Stock comp / revenue | 0.6% | 0.3% | 2.6% |
| Quality scores | |||
| Piotroski F-score | β | β | 5.0 |
| Altman Z'' | β | β | 1.0 |
| Accruals ratio | β | β2.5% | β12.6% |
Source: SEC EDGAR XBRL filings (CIK 0002052568). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.